Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-13-000196
Filing Date
2013-08-19
Accepted
2013-08-19 15:55:38
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10Q cellcyteform10qjune302013v48.htm 10-Q 279315
2 CERTIFICATIONS exhibit31.htm EX-31 12394
3 CERTIFICATION exhibit32.htm EX-32 5246
  Complete submission text file 0001056520-13-000196.txt   2076727

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20130630.xml EX-101.INS 172465
5 SCHEMA ccyg-20130630.xsd EX-101.SCH 9450
6 CALCULATION ccyg-20130630_cal.xml EX-101.CAL 13791
7 DEFINITION ccyg-20130630_def.xml EX-101.DEF 7529
8 LABEL ccyg-20130630_lab.xml EX-101.LAB 96444
9 PRESENTATION ccyg-20130630_pre.xml EX-101.PRE 71665
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 131048296
SIC: 2834 Pharmaceutical Preparations